6cph
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ==Crystal structure of | + | ==Crystal structure of the F24 TCR== |
<StructureSection load='6cph' size='340' side='right' caption='[[6cph]], [[Resolution|resolution]] 1.70Å' scene=''> | <StructureSection load='6cph' size='340' side='right' caption='[[6cph]], [[Resolution|resolution]] 1.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6cph]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6CPH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6CPH FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6cph]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6CPH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6CPH FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6cph FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6cph OCA], [http://pdbe.org/6cph PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6cph RCSB], [http://www.ebi.ac.uk/pdbsum/6cph PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6cph ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6cph FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6cph OCA], [http://pdbe.org/6cph PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6cph RCSB], [http://www.ebi.ac.uk/pdbsum/6cph PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6cph ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Rare individuals, termed HIV controllers, spontaneously control HIV infection by mounting efficient T cell responses against the virus. Protective CD4(+) T cell responses from HIV controllers involve high-affinity public T cell receptors (TCRs) recognizing an immunodominant capsid epitope (Gag293) presented by a remarkably broad array of human leukocyte antigen (HLA) class II molecules. Here, we determine the structures of a prototypical public TCR bound to HLA-DR1, HLA-DR11, and HLA-DR15 molecules presenting the Gag293 epitope. TCR recognition was driven by contacts with the Gag293 epitope, a feature that underpinned the extensive HLA cross-restriction. These high-affinity TCRs promoted mature immunological synapse formation and cytotoxic capacity in both CD4(+) and CD8(+) T cells. The public TCRs suppressed HIV replication in multiple genetic backgrounds ex vivo, emphasizing the functional advantage conferred by broad HLA class II cross-restriction. | ||
+ | |||
+ | CD4(+) T cell-mediated HLA class II cross-restriction in HIV controllers.,Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, Tan LL, Ciacchi L, Reid HH, Rossjohn J, Chakrabarti LA, Gras S Sci Immunol. 2018 Jun 8;3(24). pii: 3/24/eaat0687. doi:, 10.1126/sciimmunol.aat0687. PMID:29884618<ref>PMID:29884618</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 6cph" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Human]] | ||
[[Category: Farenc, C]] | [[Category: Farenc, C]] | ||
[[Category: Gras, S]] | [[Category: Gras, S]] |
Revision as of 05:54, 27 June 2018
Crystal structure of the F24 TCR
|
Categories: Human | Farenc, C | Gras, S | Rossjohn, J | Immune receptor | Immune system | Tcr